Epinephrine is absent in Pnmt-KO mice. The potency and the maximal effect of β 2 -adrenoceptor agonist terbutaline were lower in Pnmt-KO than in WT mice. The selective β 2 -adrenoceptor antagonist ICI-118551 antagonized the relaxation caused by terbutaline in wild type (WT) but not in Pnmt-KO mice. Isoproterenol and terbutaline induced concentration-dependent increase in tritium overflow in WT mice only. β 2 -Adrenoceptor protein density was decreased in membrane aorta homogenates of Pnmt-KO mice and this finding was supported by immunofluorescence confocal microscopy.
In conclusion, epinephrine is crucial for β 2 -adrenoceptor-mediated vasodilation and facilitation of norepinephrine release. In the absence of epinephrine, β 2 -adrenoceptor protein density was decreased in aorta cell membranes, thus potentially hindering its functional activity.
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Introduction
In contrast to adults, human neonates have plasma concentrations of norepinephrine higher than those of epinephrine (Eliot et al., 1980) . Accordingly, in the newborn canine adrenal medulla, norepinephrine is the predominant amine, whereas in adults epinephrine predominates (Paiva et al., 1994) . On the other hand, Gootman et al. (1981) showed that β -adrenoceptor-mediated vascular relaxation is immature in neonatal swine. Thies et al. (1986) also found a diminished response to the non-selective β -adrenoceptor agonist isoproterenol in human neonatal lymphocytes compared to adults. Paiva et al. (1994) also observed that there is a parallel timecourse between the postnatal increase in the epinephrine content in the adrenal medulla, and the development of β 2 -adrenoceptor-mediated smooth muscle relaxation and facilitation of norepinephrine release by sympathetic nerve stimulation, in the canine saphenous vein. In addition, epinephrine is the only biogenic catecholamine that has affinity for β 2 -adrenoceptors at physiologically relevant concentrations, whereas both epinephrine and norepinephrine are potent β 1 -adrenoceptors agonists (Lands et al., 1967a; Lands et al., 1967b ).
Thus, it was suggested that there is a link between epinephrine and the development of β 2 -adrenoceptor-mediated effects (Paiva et al., 1994; Guimaraes and Moura, 2001 ). However, it remains to be proved whether the development of β 2 -adrenoceptor-mediated effects is triggered by epinephrine or by other causes which might simultaneously induce epinephrine production and the functional development of the responses to β 2 -adrenoceptor stimulation.
It has been difficult to decipher the role of epinephrine with the commonly used adrenal medullectomy because this procedure can damage the adrenal cortex, altering the release of corticosteroids, and it also removes the release of other adrenal amines and peptides, such as norepinephrine, chromogranin A, catestatin and neuropeptide Y (Harrison and Seaton, 1966 ).
An alternative approach is the use of phenylethanolamine-N-methyltransferase (Pnmt) inhibitors to block epinephrine synthesis in vivo (Bondinell et al., 1983) , but most of them also inhibit monoamine oxidase (Mefford et al., 1981) and α -adrenoceptors (Feder et al., 1989) . These drawbacks for the elucidation of the specific role of epinephrine in the development of β 2 -This article has not been copyedited and formatted. The final version may differ from this version.
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adrenoceptor subtype are avoided by doing experiments in an epinephrine-deficient animal model generated by knocking out the Pnmt gene (Ebert et al., 2004; Ebert et al., 2008; ShararaChami et al., 2010) . Therefore, the aim of this study was to characterize the role of epinephrine on β -adrenoceptor-mediated aorta relaxation and facilitation of norepinephrine release from sympathetic nerve endings using Pnmt-knockout (Pnmt-KO) and wild-type (WT) mice.
This article has not been copyedited and formatted. The final version may differ from this version. and stored at -80 ºC until used for quantification of catecholamines. Alternatively the aortas were dissected, removed and used for functional or molecular studies.
Quantification of catecholamines. Alumina extracts from plasma and tissue samples were injected in reverse-phase HPLC column for separation of norepinephrine and epinephrine, which were quantified by electrochemical detection, as previously described (Paiva et al., 1994; Moreira-Rodrigues et al., 2009) . The detection limit is between 350 and 1000 fmol.
Postjunctional functional studies. Pnmt-KO and WT mice aortas were placed in KrebsHenseleit solution bubbled with 95% O 2 and 5% CO 2 , cut in rings (1-2 mm) and mounted in a myograph (DMT, Aarhus, Denmark). Each aorta ring was allowed to stabilize for 1 h.
Afterwards, optimal resting tension was settled using a standardized normalization procedure (Mulvany and Halpern, 1977) . Then, the arteries were precontracted with phenylephrine (α 1 -adrenoceptor agonist) to about 60% of the maximum contraction, a level which has been shown This article has not been copyedited and formatted. The final version may differ from this version. to be optimal to obtain β -adrenoceptor-mediated relaxation (Guimaraes, 1975 Percentage changes of Sn S1 -1 ratios induced by drugs added after S1 were calculated. Finally, concentration-response curves to isoproterenol and terbutaline were obtained.
Protein quantification. Three mice aortas in each sample were homogenized in RIPA buffer (65 mM Tris-HCl, pH 7.4; 154 mM NaCl; 10 M Na 2 EDTA; 1% IGEPAL; 6 mM sodium deoxycholate; 1 µM PMSF; 1 µM NaF; 1 µM Na 3 VO 4 ; 5 µg/mL leupeptin; 5 µg/mL aprotinin; 5 µg/mL pepstatin) and were ultra-centrifuged (4˚C, 100 000×g, 65 min), the pellets were suspended in RIPA buffer, sonicated and then collected for protein quantification (membrane fraction of aorta). Protein concentration was determined using a protein assay kit (Bio-Rad Laboratories, Hercules, CA, USA), using bovine serum albumin as standard.
Western Blot. Membrane fraction of aorta homogenates were diluted with RIPA buffer and then with 6:1 sample buffer (0.35 M Tris-HCl, pH 6.8; 4% SDS; 30% glycerol; 9.3% DTT; 0.01% bromophenol blue) and boiled at 95˚C for 5 min. Samples (40 µg) were separated by SDS-PAGE with 10% polyacrylamide gel and then transferred onto nitrocellulose membranes (BioRad Laboratories). Blots were blocked for 1 h with 5% non-fat dry milk in TBS, incubated with a rabbit polyclonal anti-β 2 -adrenoceptor antibody (1:125; Santa Cruz Biotechnology, Dallas, TX, USA) in 2.5% non-fat dry milk in TBS-T, overnight, at 4˚C, then washed and incubated with an IRDye 800 goat anti-rabbit secondary antibody (1:10000; Rockland, Gilbertsville, PA, bovine serum albumin, 0.3% Triton X-100, 0.025% NaN 3 in PBS) for 60 min with constant stirring. Subsequently, samples were incubated overnight (4 ºC) with a rabbit polyclonal anti-β 2 -adrenoceptor antibody (1:50; Santa Cruz Biotechnology) diluted in dilution buffer solution (5% fetal bovine serum, 0.5% bovine serum albumin, 0.3% Triton X-100, 0.025% NaN 3 in PBS).
Afterwards, tissue sections were washed and incubated for 90 min (at room temperature in the dark) with an anti-rabbit secondary antibody Alexa Fluor 488 (1:1500; Molecular Probes, Eugene, OR, USA) diluted in dilution buffer solution. Negative controls were performed using the secondary antibody alone. Finally samples were washed and mounted on optical-quality glass slides. Vectashield with DAPI was used as mounting media (Vector Laboratories, Burlingame, CA, USA). Observations and analyses were performed with a laser-scanning confocal microscope (Olympus Fluoview, FV1000, Tokyo, Japan) (Carneiro et al., 2014) .
Drugs. Isoflorane 100%, Isoflo, was obtained from Abbott laboratories (Queenborough, UK). (- 
Results

Epinephrine and norepinephrine content in adrenal glands
Epinephrine content was baseline levels in the adrenal glands and plasma of Pnmt-KO mice when compared to WT mice, and it was below the detection level in the aorta samples of both groups (Table 1 ). In contrast, the norepinephrine content of the adrenal gland was higher in
Pnmt-KO than in WT mice; however, norepinephrine levels in plasma and aorta were similar between groups (Table 1) .
Postjunctional β -adrenoceptor-mediated responses in aorta rings
In aortas previously contracted with phenylephrine, terbutaline ( Figure 1A ) and dobutamine n = 7-8). In the aorta of WT mice, both isoproterenol ( Figure 3A ) and terbutaline ( Figure 3B) increased the overflow of tritium elicited by electrical stimulation in a concentration-dependent manner, with a pEC 50 of 9.36 ± 0.55 (n = 7-8) and a maximal effect of 167.3 ± 37.5% (n = 7-8)
for isoproterenol and a pEC 50 of 7.65 ± 0.94 (n = 6) and a maximal effect of 173.3 ± 31.3% (n = 6) for terbutaline. This facilitatory effect of isoproterenol and terbutaline on norepinephrine release was absent in Pnmt-KO mice ( Figure 3A and 3B) . In Pnmt-KO mice curves failed to converge to a sigmoidal equation (Figure 3 ).
Quantification and visualization of β 2 -adrenoceptors in aorta
The protein density of β 2 -adrenoceptors (~61 KDa) in membrane aorta homogenates was significantly (p < 0.05) lower in Pnmt-KO as compared with WT mice (Figure 4 ). This finding was also evidenced by immunofluorescence confocal microscopy ( Figure 5 ). In WT mice aorta rings, the β 2 -adrenoceptor immunofluorescent labeling is concentrated mainly in the media layer (where smooth muscle cells are the most abundant cell type), but also in the endothelium. 
Discussion
Our results show that epinephrine-deficient mice do not develop aorta β 2 -adrenoceptor-mediated responses both at a postjunctional level (β 2 -adrenoceptor dependent relaxation) and at a prejunctional level (facilitation of norepinephrine release form sympathetic nerve endings), strengthening the hypothesis that epinephrine is critical for the functional development of β 2 -adrenoceptor-mediated responses.
The Pnmt-KO mouse is an epinephrine-deficient mouse model, generated by knocking out the Pnmt gene (Ebert et al., 2004; Ebert et al., 2008; Sharara-Chami et al., 2010) . The absence of Pnmt mRNA expression alters epinephrine biosynthesis. Accordingly, we found only baseline levels of epinephrine in the adrenal medulla and plasma of Pnmt-KO mice. Our results agree with those of Sun et al. (2008) , showing that epinephrine is absent from the adrenal gland and plasma of Pnmt-KO mice, while the norepinephrine content of the adrenal glands is significantly increased. This might be due to an upstream accumulation of norepinephrine that would normally be methylated to epinephrine.
In conduit arteries (thoracic aorta and carotid artery) of mice, both β 1 and β 2 -adrenoceptors mediate smooth muscle relaxation Rohrer et al., 1999; Chruscinski et al., 2001) . We have chosen the mouse aorta because: (1) it contains postjunctional relaxing β 2 -adrenoceptors; (2) it is easy to mount in the myograph to evaluate β 2 -adrenoceptor-mediated relaxation and (3) it has enough nerve terminals to evaluate prejunctional β -adrenoceptor-mediated responses.
Our results showed that dobutamine (β 1 -adrenoceptor agonist) and terbutaline (β 2 -adrenoceptor agonist) caused concentration-dependent relaxation of aorta rings precontracted with phenylephrine, in both WT and Pnmt-KO mice. In WT mice, terbutaline caused aorta relaxation at β 2 -selective concentrations, whereas in Pnmt-KO mice very high (non-selective)
concentrations of terbutaline were required to produce relaxation. Actually, the potency and the maximal response to β 2 -adrenoceptor stimulation by terbutaline were lower in Pnmt-KO mice than in WT mice. In addition, the relaxing effect of terbutaline in Pnmt-KO mice, contrary to that observed in WT mice. Overall, these results suggest a loss of β 2 -adrenoceptor-mediated relaxation in the aorta of Pnmt-KO compared to WT mice. In agreement with our results is the fact that after adrenalectomy it was observed impaired formation of high-affinity myocardial β -adrenoceptor complexes (Davies et al., 1981) and after adrenal demedullation it was observed a decrease in β -adrenoceptor cardiac density in rats (Tumer et al., 1990 ).
On the other hand, no differences were observed in β 1 -adrenoceptor-mediated aorta relaxation to dobutamine between the two groups, since the potency and the maximal response to dobutamine were similar. In addition, CGP 20712 A (a β 1 -adrenoceptor antagonist) antagonized the effect of dobutamine with similar potency in both groups. Thus, our results suggest that both β 1 and β 2 -adrenoceptors mediate aortic relaxation in WT mice, but that only β 1 -adrenoceptors are operative in the absence of epinephrine, as it happens in the Pnmt-KO mice. This might explain why Pnmt-KO mice show normal basal blood pressure values, but blood pressure dramatically increases during treadmill exercise compared to WT mice (Bao et al., 2007) . In Pnmt-KO mice at rest, β 1 -adrenoceptors may be sufficient to produce vasodilation and control blood pressure.
One can speculate that under stressful conditions this mechanism might not be enough because β 2 -adrenoceptor-mediated vasodilator response is blunted and then, blood pressure rises. In agreement with this hypothesis is the fact that β 2 -adrenoceptor knockout mice also have a normal basal resting blood pressure and become hypertensive during exercise .
Conversely, we did not observe β 3 -adrenoceptor-mediated vasorelaxation induced by CL 316243 in WT mice, which is in agreement with the fact that in aortas from β 1 β 2 -adrenoceptor double knockout mice, the β -agonist isoproterenol does not cause any relaxation (Chruscinski et al., 2001 ). These findings suggest that β 3 -adrenoceptors do not contribute to the adrenoceptormediated vasodilation in mice aorta.
In the aorta of WT mice, the facilitatory effect of isoproterenol on norepinephrine release was similar to that found by other authors in mice spleen and atria (Trendelenburg et al., 2000) . To
This article has not been copyedited and formatted. The final version may differ from this version. our knowledge, data from this study show for the first time that prejunctional β -adrenoceptors in particular of the β 2 subtype, are present in the mouse aorta. In addition, we report here the absence of β 2 -adrenoceptor-mediated effect on norepinephrine release in Pnmt-KO mice. In agreement with our results it had been previously shown that carteolol (non-selective β -adrenoceptor antagonist) does not inhibit 3 H-norepinephrine release in a concentration dependent manner induced by nerve stimulation from pulmonary arteries in guinea-pigs subjected to adrenalectomy or adrenodemedullation, contrary to sham-operated animals (Misu et al., 1989) . On the other hand, putative prejunctional β 1 -adrenoceptor-mediated effects were not evaluated since in all tissues tested so far presynaptic β -adrenoceptors are of the β 2 subtype (Kahan and Hjemdahl, 1987; Molderings et al., 1988; Trendelenburg et al., 2000; Todorov et al., 2001) . Although compensatory changes may occur, the presence of presynaptic β 1 or β 3 -adrenoceptors seems rather unlikely since we did not observe any β -adrenoceptor induced effect in the release of norepinephrine using isoproterenol (a non-selective β -agonist).
The lower β 2 -adrenoceptor protein density observed in aorta of Pnmt-KO mice may be correlated with decreased coupling to stimulatory G-protein and lower cAMP levels, which may justify impairments of vasorelaxation and of norepinephrine release facilitation upon the presence of β 2 -adrenoceptors in the endothelial lining of mice aortic rings. Given that β 2 -adrenoceptors located in vascular endothelial cells may regulate NO release (Conti et al., 2013) , one cannot exclude that relaxation of mouse aortic rings produced by β 2 -adrenoceptor agonists involves this mechanism.
The results from this study agree with the fact that the time-course of postnatal increase in epinephrine content of the adrenal medulla positively correlates with the development of β 2 -adrenoceptor-mediated effects, as previously described in the canine saphenous vein (Paiva et al., 1994) . This view is supported by the diminished response of β -adrenoceptors in lymphocytes from human newborns compared to adults (Thies et al., 1986) and lymphocytes almost exclusively express adrenoceptors of the β 2 -subtype (Sanders, 2012) . Interestingly, it was found that treatment of newborn rats with β 2 -adrenoceptor agonists caused a surprising sensitization of β -adrenoceptors instead of evoking desensitization (Kudlacz and Slotkin, 1990 ).
Also, a single exposure of newborn rats to terbutaline induces a strong sensitization of the β 2 -adrenoceptor-mediated stimulation of adenylyl cyclase activity in the brainstem and cerebellum (Slotkin and Seidler, 2006) . Epinephrine is the only biogenic catecholamine that has a good affinity for β 2 -adrenoceptors (Lands et al., 1967a; Lands et al., 1967b) and it is conceivable that it can act similarly causing sensitization of β 2 -adrenoceptors. Since Pnmt-KO mice were never exposed to epinephrine, β 2 -adrenoceptor function does not appear to efficiently develop.
One limitation of our experimental design is the limited selectivity of terbutaline and dobutamine at β 2 -adrenoceptors and β 1 -adrenoceptors, respectively (Ruffolo et al., 1984; Young et al., 2002; Baker, 2005) . This prevents us from using higher nonselective concentrations of those agonists because the mouse aorta relaxes to activation of both subtypes of β -adrenoceptors.
In conclusion, epinephrine is crucial for the development of adrenoceptor protein density was decreased in aorta cell membranes, thus potentially hindering its functional activity.
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